Sudeep Pharma IPO KPI Information
The Sudeep Pharma IPO KPI (Key Performance Indicators) provide valuable insights into the company's financial efficiency, profitability, and capital utilization. Key metrics such as Return on Equity (ROE), Return on Capital Employed (ROCE), Debt-to-Equity Ratio, Return on Net Worth (RoNW), Price-to-Book Value (P/BV), and PAT Margin help investors evaluate the company's operational performance and financial health before investing in the IPO.
Based on the latest reported financial year (KPI as of Mon), Sudeep Pharma Limited reported RoNW of 27.88%, PAT Margin of 27.63%, and Debt-to-Equity Ratio of 0.2. These key financial ratios provide investors with a snapshot of the company's profitability, capital efficiency, leverage, and overall financial strength.
Sudeep Pharma IPO Key Performance Indicators
- Return on Net Worth (RoNW): 27.88%
- PAT Margin: 27.63%
- Debt-to-Equity Ratio: 0.2
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Sudeep Pharma Limited KPI Information
| Particular | KPI as of Mon | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Debt / Equity | 0.2 | 0.17 | 0.32 |
| RoNW % | 27.88 | 27.91 | 30.59 |
| Pat Margin % | 27.63 | 37.09 | 27.54 |
Return Ratio
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Market Cap of Sudeep Pharma Limited?
The post-IPO market capitalisation (market cap) of Sudeep Pharma Limited is approximately ₹0 crore, based on the IPO issue price and the company's post-issue equity share capital. Market cap represents the total market value of a company's outstanding shares and is widely used by investors to assess the company's size and valuation.
What is the ROE of Sudeep Pharma Limited?
Sudeep Pharma Limited reported a Return on Equity (ROE) of 0% as of KPI as of Mon. ROE measures how efficiently the company generates profits from shareholders' equity. A higher ROE generally indicates strong financial performance and effective management of shareholder funds.
What is the ROCE of Sudeep Pharma Limited?
The Return on Capital Employed (ROCE) of Sudeep Pharma Limited stood at 0% as of KPI as of Mon. ROCE measures how efficiently the company uses its total capital to generate profits. A higher ROCE indicates better capital efficiency and operational performance.
What is the Net Profit Margin (PAT Margin) of Sudeep Pharma Limited?
Sudeep Pharma Limited reported a Profit After Tax (PAT) Margin of 27.63% as of KPI as of Mon. PAT Margin shows the percentage of revenue that remains as net profit after all operating expenses, interest, and taxes. A higher margin reflects better profitability and cost management.
What is the Return on Net Worth (RoNW) of Sudeep Pharma Limited?
The Return on Net Worth (RoNW) of Sudeep Pharma Limited was 27.88% as of KPI as of Mon. RoNW measures the company's ability to generate profits from shareholders' net worth and is an important indicator of overall financial efficiency.